Bone Densitometer Market Size

Bone Densitometer Market size was valued at USD 295.3 million in 2022 and is projected to grow at over 4.9% CAGR from 2023 to 2032. Bone densitometry, also known as dual-energy X-ray absorptiometry (DXA or DEXA), is the most common technique used by bone densitometers. It is a medical device used to measure the density and strength of bones. It is primarily employed in the diagnosis and management of osteoporosis, a condition characterized by low bone density and increased susceptibility to fractures.

Moreover, the rising geriatric population base across the world that is highly susceptible to suffer from several bone disorders will positively influence the bone densitometer market growth. For instance, according to the United Nations (UN) Department of Economic and Social Affairs estimates, the number of individuals aged 65 years or over is anticipated to triple to reach nearly 1.5 billion by the year 2050.

Further, bone densitometers are essential tools in assessing bone health in older adults and guiding appropriate preventive measures and treatment strategies, thereby owing to the abovementioned factors the adoption rate of bone densitometer devices is on a rise. Additionally, an upsurge in the incidence of osteoporosis and vitamin D deficiency emphasizes the need for bone densitometry as a valuable tool in screening, diagnosis, and management of these conditions. By accurately assessing bone health, bone densitometers assist in risk assessment, treatment planning, and monitoring of these conditions, ultimately improving patient outcomes.